Cargando…
Effect of E-OJ-01 on Left Ventricular Ejection Fraction and Myocardial Oxygen Consumption: A Randomized, Double-Blind, Placebo-Controlled Study
PURPOSE: E-OJ-01 (Oxyjun(TM)), a proprietary, standardized aqueous extract of Terminalia arjuna (TA) bark, has previously shown promising cardiovascular health benefits in healthy young athletic adults and is now being tested to determine its ability to support left ventricular ejection fraction and...
Autores principales: | Srivastava, Shalini, Girandola, Robert N, Abedon, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637339/ https://www.ncbi.nlm.nih.gov/pubmed/36349244 http://dx.doi.org/10.2147/JMDH.S381028 |
Ejemplares similares
-
Effect of E-PR-01 on Activity-Induced Acute Knee Joint Discomfort in Healthy Individuals: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study
por: Srivastava, Shalini, et al.
Publicado: (2023) -
Effect Of E-OA-07 On Improving Joint Health And Mobility In Individuals With Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study
por: Srivastava, Shalini, et al.
Publicado: (2019) -
Deciphering the Autoantibody Response to the OJ Antigenic Complex
por: Fritzler, Marvin J., et al.
Publicado: (2023) -
Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020) -
Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)